Change in the Media - The Clinic of Change

Change in the Media

Mental Health: We Need to Focus More on Therapeutic Innovation | SAPO

A rarely discussed blind spot: treatment-resistant cases. It is estimated that between 30% and 40% of patients with depression develop forms of the disorder that are resistant to conventional pharmacological treatment.

September 9, 2026

Burnout: “The problem begins long before someone is no longer able to work” | Human Resources Portugal

Mental Health in the Workplace: From Prevention to Treatment. In an interview with Human Resources, Victor Amorim Rodrigues argues that organizations must stop merely reacting to illness and start investing in people.

August 21, 2026

Miguel Esteves Carneiro: “Winning a game activates the same brain circuits as cocaine”

The line between entertainment and addiction is thinner than it seems. Psychiatrist Miguel Esteves Carneiro, of The Clinic of Change, explains to Notícias ao Minuto how pathological gambling takes hold, who is at risk, and how it is treated.

August 13, 2026

Victor Amorim Rodrigues: “We must be prudent, but not resistant to change on principle”

In an interview with Jornal Médico, the clinical director of The Clinic of Change argues that ketamine-assisted psychotherapy and Transcranial Magnetic Stimulation should be part of the clinical algorithm for treatment-resistant depression and should not be viewed as a last resort.

August 12, 2026

Victor Amorim Rodrigues: “To talk about psychedelics is to talk about the future of mental health”

In an opinion piece published in Saúde e Bem Estar, the clinical director of The Clinic of Change argues that psychedelic-assisted psychotherapy is an effective treatment for treatment-resistant depression.

Victor Amorim Rodrigues: “Neuroplasticity opens the window; psychotherapy guides what we do with it” | HealthNews

In an interview with HealthNews, the clinical director of The Clinic of Change discusses ketamine, psychedelics, and what Portugal needs to do to avoid falling behind.

David J. Nutt: “It’s outrageous to deny medical access to psychedelics” | SÁBADO Magazine

Drawing on half a century of brain research, David J. Nutt argues that psychedelics could revolutionize the treatment of depression and other mental illnesses. What’s missing, he says, isn’t science—it’s political will.

The Clinic of Change in the media: ketamine and treatment-resistant depression

The 3rd Scientific Conference and the study on the use of ketamine in the treatment of treatment-resistant depression dominated media coverage of The Clinic of Change—from newspapers to radio.